With more than twenty years of pharmaceutical industry experience, Nailesh A. Bhatt brings a unique global perspective, valuable expertise, and a robust network to the Board of CoreRx.
A serial entrepreneur, Mr. Bhatt is Managing Director of Proximare – a strategic advisory firm that develops growth strategies for companies in the pharmaceutical and healthcare industries, including strategy development, licensing, mergers, acquisitions, and joint ventures. Proximare clients include large pharma, generics, CROs, CMOs, wholesalers, distributors, PBMs, payers, retailers, GPOs, and private equity groups. Proximare has successfully completed multiple M&A transactions, including cross-border deals. While at Proximare, Mr. Bhatt also launched Proximare Life Sciences Fund to invest in innovative biosimilars and emerging companies.
In addition, Mr. Bhatt is Founder and CEO of VGYAAN Pharmaceuticals which is focused on developing and commercializing clinically critical drugs.
Previously, Mr. Bhatt was the founder of BulkDrugs.com with presence in the US, India, and Japan. Before that, Mr. Bhatt worked in increasing roles and responsibilities at Arthur Andersen, SEPPIC, and Sidmak Laboratories.
In addition to CoreRx, Mr. Bhatt serves as a Member of the Board of Directors of Azurity Pharmaceuticals, Sonnet BioTherapeutics (NASDAQ: SONN), and VGYAAN Pharmaceuticals.
Mr. Bhatt is a sought-after speaker at various industry conferences and has presented at the India Economic Summit organized by the World Economic Forum, the Federal Trade Commission, DCAT, and more.